Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib improved multiple immune-related conditions in one patient.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

Adalimumab improved folliculitis decalvans in most patients.

The cream effectively treats scalp psoriasis, improving symptoms and quality of life, with high patient satisfaction.

New treatment for hair loss using special microneedles shows promise in reducing inflammation and promoting hair growth.

Tofacitinib treatment for hair loss may worsen acne.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

Combining triamcinolone acetonide with cryotherapy may reduce scalp hair loss more than using triamcinolone alone.

The serum with microneedling device improves hair loss treatment effectively and safely.

Baricitinib works better in adolescents than adults for treating severe alopecia areata.

The serum with microneedling effectively treats alopecia areata by enhancing drug delivery and is safe and patient-friendly.

Start with 2.5 mg/mL triamcinolone acetonide for scalp alopecia areata and increase if needed.

The new patch for treating mouth sores releases medicine slowly, sticks well, and helps healing without the side effects of current creams.

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Topical tretinoin may increase beard hair density.

Oral isotretinoin and cyproterone compound are equally effective for treating acne in women with cutaneous hyperandrogenism.

Upadacitinib effectively treats skin conditions like eczema and psoriasis and is becoming more widely used and affordable.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

An 8-year-old girl with vitiligo developed extra hair growth on her knee after using tacrolimus ointment.

Adalimumab effectively stabilized severe folliculitis decalvans, preventing further hair loss and inflammation.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

Two women had skin reactions from a hair loss treatment and got better after stopping use.

Diphenylcyclopropenone (DPCP) is more effective than anthralin for treating resistant alopecia areata.